Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical OncologyhrHPV-negative cervical cancers appear to fare far worse than hrHPV-positive tumors. But what is the clinician to do with that knowledge?

This editorial reflects on the work by Lei and colleagues in teasing out hrHPV-negative vs. positive ovarian cancers with a 15-year follow up. But what to do with the knowledge?

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form